The translational biology of remyelination: past, present, and future.
about
CNS Remyelination and the Innate Immune SystemGlial development: the crossroads of regeneration and repair in the CNSStem cells in the nervous systemPathophysiology of glia in perinatal white matter injury.Advanced MRI and staging of multiple sclerosis lesionsDefined and Scalable Differentiation of Human Oligodendrocyte Precursors from Pluripotent Stem Cells in a 3D Culture System.VCAM1 acts in parallel with CD69 and is required for the initiation of oligodendrocyte myelination.Expression of the Human Herpesvirus 6A Latency-Associated Transcript U94A Disrupts Human Oligodendrocyte Progenitor Migration.Heterogeneity in oligodendroglia: Is it relevant to mouse models and human disease?How do corticosteroids influence myelin genesis in the central nervous system?Remyelination therapy goes to trial for multiple sclerosisThe role of immune cells, glia and neurons in white and gray matter pathology in multiple sclerosis.Oligodendrocyte precursor cells synthesize neuromodulatory factorsContribution of Schwann Cells to Remyelination in a Naturally Occurring Canine Model of CNS Neuroinflammation.Glia Disease and Repair-RemyelinationFibroblast growth factor signaling in oligodendrocyte-lineage cells facilitates recovery of chronically demyelinated lesions but is redundant in acute lesions.Apcdd1 stimulates oligodendrocyte differentiation after white matter injury.Retinoid X receptor activation reverses age-related deficiencies in myelin debris phagocytosis and remyelinationG protein-coupled receptor 37 is a negative regulator of oligodendrocyte differentiation and myelination.Pre-Existing Mature Oligodendrocytes Do Not Contribute to Remyelination following Toxin-Induced Spinal Cord Demyelination.Salvianolic acid B protects the myelin sheath around injured spinal cord axons.Persistent 7-tesla phase rim predicts poor outcome in new multiple sclerosis patient lesions.Dynamic imaging of individual remyelination profiles in multiple sclerosis.Multiple sclerosis: experimental models and reality.Creatine Enhances Mitochondrial-Mediated Oligodendrocyte Survival After Demyelinating InjuryGlial response during cuprizone-induced de- and remyelination in the CNS: lessons learned.Neurotransmitter signaling in white matter.Remyelination and multiple sclerosis: therapeutic approaches and challenges.Human oligodendrocytes in remyelination research.From demyelination to remyelination: the road toward therapies for spinal cord injury.Canonical Wnt signaling in the oligodendroglial lineage--puzzles remain.Magnetic nanoparticles for oligodendrocyte precursor cell transplantation therapies: progress and challengesIntracellular Protein Shuttling: A Mechanism Relevant for Myelin Repair in Multiple Sclerosis?Oligodendrocytes in a Nutshell.Spring cleaning: time to rethink imaging research lines in MS?Extracellular cues influencing oligodendrocyte differentiation and (re)myelinationAndrostenediol Reduces Demyelination-Induced Axonopathy in the Rat Corpus Callosum: Impact on Microglial Polarization.Nogo-A Antibodies for Progressive Multiple Sclerosis.Adhesion G-protein coupled receptors and extracellular matrix proteins: Roles in myelination and glial cell development.Human Wharton's Jelly-Derived Stem Cells Display Immunomodulatory Properties and Transiently Improve Rat Experimental Autoimmune Encephalomyelitis.
P2860
Q26747242-D483F956-91B0-4E39-BBFB-478C7B4CE080Q26823697-23BCC6DC-D610-4809-89EB-457CDF5E4F8FQ27027574-07AB6350-5BDB-4F7F-BE0C-A78C18AE21FEQ30790294-C32F1F48-F903-4D09-BF9B-09F8B09DE5F9Q30825494-9CB897CC-61B2-4E97-8712-EB44C7EC71BEQ33795348-0B04A932-BAA4-4BA4-8579-FF24939353C7Q33813417-7BC7CB70-B31A-4866-B558-111BC819C14CQ33822315-D9071099-A38C-493E-A134-A0DFECDCC62EQ33911142-B2C832A3-8569-4EE5-9E7F-28F98A62F114Q34095959-65C56E91-99A1-40EB-BF95-5E78739A1AFCQ34368564-BD853F31-A2C2-4E44-A97D-EAFD368ED1AEQ34468304-77343769-7D07-47FD-AA8D-9BF229ABC2EBQ34476069-ED22C413-F79E-4DB0-A5B7-C6FFF5BA3627Q35702252-79E603AC-2095-4DD2-B1E9-FC81A4D358BBQ35795587-8C347406-0486-4A0B-A1ED-48C987E17EACQ35946418-0FC1363E-55B2-4FE8-9E38-87777106C31BQ35946482-AC64484B-DAA0-43E7-B7A7-D26853C7538FQ36344854-3771D73E-64D7-4C08-87DF-9722F3473BE3Q36690180-C613AD6B-C747-4E35-A7DD-B6E869729784Q36753717-5EE3AB40-36CD-472E-9575-3D1C8AD7CBA5Q36790871-30941885-F780-404B-84E2-B32B50242104Q37042300-89E781A5-A53D-4C44-9011-AA74EE269928Q37221998-39DC5E23-B2D9-49D2-9E86-BE060751412EQ37596784-429017D3-02F7-44F3-9FFD-72A9E9B33B3FQ37633504-F51B8796-F673-464B-81A7-A0A6834A3210Q37634375-5D685D28-76CE-4F42-AB18-5EE0D9D23E02Q38206164-3079EF20-4016-4AC9-92EE-DB812EC01E1EQ38238466-F7FCD050-FE13-47EA-984A-78A2A3943835Q38271155-37C78F69-D66B-4C80-B9B1-677CADFD8997Q38366783-C0271C51-AB8F-4F0D-814A-6790199B963FQ38381699-42238697-1180-4267-AD8E-369511E2306AQ38521746-1180B5D3-BA9E-4698-9544-569550B9DB35Q38543597-D476A9F8-0C6F-4494-B554-B5C568D8B06BQ38590090-5FC370E6-5E5B-4DBA-822A-5DD929D5BE01Q38737202-84DBB16C-5C7A-4ABB-9440-1DD3544B8682Q38789322-4062A4D3-9CA0-45DE-80DE-CBAAD7550E82Q38915955-39217488-1868-437E-9330-A687B3B94276Q39010894-2C6F0B60-801B-403A-8578-3EEB6FCDCC76Q39012388-AE3E084C-26BA-4593-81A8-30C0957EFC54Q39114043-13188376-886A-4914-BC94-BC7B1DFB6326
P2860
The translational biology of remyelination: past, present, and future.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
The translational biology of remyelination: past, present, and future.
@en
type
label
The translational biology of remyelination: past, present, and future.
@en
prefLabel
The translational biology of remyelination: past, present, and future.
@en
P2860
P356
P1433
P1476
The translational biology of remyelination: past, present, and future.
@en
P2093
Vittorio Gallo
P2860
P304
P356
10.1002/GLIA.22622
P577
2014-01-20T00:00:00Z